Multiple regions have released procurement intentions for the 2026 to 2027 flu season, with the budget unit price for trivalent influenza split-virus vaccine at approximately 9 yuan per dose. According to an incomplete tally by Red Star Capital Bureau, as of press time no fewer than 10 provinces have issued relevant procurement intentions, mainly targeting key groups such as rural residents aged 65 and above and primary and secondary school students in compulsory education. The main vaccine type procured is the 0.5 milliliter trivalent influenza split-virus vaccine for adults and children aged three and above. Among them, Hunan Province plans to procure 3.7611 million doses with a budget of 33.84 million yuan; Hubei Province plans to procure 2.8135 million doses with a budget of 25.32 million yuan; Heilongjiang Province plans to procure 1.0264 million doses with a budget of 9.2374 million yuan. Although Anhui, Hainan, Shaanxi and other regions have not disclosed specific dose numbers, they have listed budgets of 30.42 million yuan, 4.77 million yuan and 18.3425 million yuan respectively. This budget price has stabilized from last year's low of 5.5 yuan per dose, while the price of quadrivalent flu vaccines in the self-pay market remains relatively stable, with adult pre-filled syringes priced between 85 and 88 yuan per dose.
Hualan Biological Bacterin Inc.Multiple provinces issue procurement intentions for flu vaccines, boosting demand for vaccine manufacturers like Hualan Biological.
Jiangsu GDK Biotechnology Co LtdMultiple provinces issue procurement intentions for flu vaccines, boosting demand for vaccine manufacturers like Jiangsu GDK.